BioInvent International announces manufacturing agreement with undisclosed US cell therapy company
Nov 20, 2018 - Global Banking News
BioInvent International AB (STO:BINV) announced on Tuesday the signing of a manufacturing agreement with an undisclosed US cell therapy company for the production of cGMP compliant material to support their clinical development programmes.
BioInvent International is focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies to treat cancer.
This manufacturing agreement is expected to generate revenues of approximately USD1.5m, mainly in 2...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
